The prevalence of nausea and vomiting in patients with advanced cancer varies, but it generally increases towards the end of life. Nausea and vomiting can be distressing and debilitating for patients, and can affect quality of life significantly. This article discusses the assessment of nausea and vomiting, current understanding of the emetic pathways, and pharmacological management of nausea and vomiting in patients with advanced cancer at the end of life.
Nursing Standard. 32, 10, 53-63. doi: 10.7748/ns.2017.e10993
Correspondence Peer reviewThis article has been subject to external double-blind peer review and checked for plagiarism using automated software
Conflict of interestNone declared
RevalidationPrepare for revalidation: read this CPD article, answer the questionnaire and write a reflective account: rcni.com/reflective-account
To write a CPD articlePlease email tanya.fernandes@rcni.com. Guidelines on writing for publication are available at: rcni.com/writeforus
Received: 24 August 2017
Accepted: 19 September 2017
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
